These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3219158)

  • 21. Budesonide once-daily in seasonal allergic rhinitis.
    Ross JR; Mohan G; Andersson B; Taylor MD; Richardson PD
    Curr Med Res Opin; 1991; 12(8):507-15. PubMed ID: 1764954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Once daily intranasal fluticasone propionate is effective for perennial allergic rhinitis.
    Banov CH; Woehler TR; LaForce CF; Pearlman DS; Blumenthal MN; Morgan WF; Frazer H; Southern DL; Gold B; Field E
    Ann Allergy; 1994 Sep; 73(3):240-6. PubMed ID: 8092559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A parallel-group comparison of budesonide and beclomethasone dipropionate for the treatment of perennial allergic rhinitis in adults.
    al-Mohaimeid H
    J Int Med Res; 1993; 21(2):67-73. PubMed ID: 8243791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Budesonide - a new nasal steroid.
    Pipkorn U; Rundcrantz H; Lindqvist N
    Rhinology; 1980 Dec; 18(4):171-5. PubMed ID: 7010515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety of nasal budesonide in the long-term treatment of children with perennial rhinitis.
    Möller C; Ahlström H; Henricson KA; Malmqvist LA; Akerlund A; Hildebrand H
    Clin Exp Allergy; 2003 Jun; 33(6):816-22. PubMed ID: 12801318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intranasal ciclesonide coadministration with inhaled fluticasone propionate-salmeterol does not suppress cortisol in allergic rhinitis patients.
    Kim K; Quesada J; Szmaydy-Rikken N; Darken P; Shah T
    J Asthma; 2007 Sep; 44(7):515-20. PubMed ID: 17885853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Perennial rhinitis: antihistaminic and anti-inflammatory treatment].
    Eseverri JL; Botey J; Marín AM
    Allergol Immunopathol (Madr); 1997; 25(1):1-9. PubMed ID: 9148645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Budesonide and nasal allergen challenge testing in man.
    Pipkorn U
    Allergy; 1982 Feb; 37(2):129-34. PubMed ID: 7137521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of budesonide in perennial rhinitis.
    Balle VH
    Eur J Respir Dis Suppl; 1982; 122():197-204. PubMed ID: 6754416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Montelukast decreased exhaled nitric oxide in children with perennial allergic rhinitis.
    Hung CH; Hua YM; Hsu WT; Lai YS; Yang KD; Jong YJ; Chu YT
    Pediatr Int; 2007 Jun; 49(3):322-7. PubMed ID: 17532829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term safety of budesonide nasal aerosol: a 5.5-year follow-up study.
    Pipkorn U; Pukander J; Suonpää J; Mäkinen J; Lindqvist N
    Clin Allergy; 1988 May; 18(3):253-9. PubMed ID: 3396194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allergic perennial and non-allergic, vasomotor rhinitis treated with budesonide nasal spray.
    Balle VH; Pedersen U; Engby B
    Rhinology; 1980 Sep; 18(3):135-42. PubMed ID: 6997974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of budesonide on the cytokine pattern in patients with perennial allergic rhinitis.
    Ciprandi G; Tosca MA; Cirillo I; Vizzaccaro A
    Ann Allergy Asthma Immunol; 2003 Nov; 91(5):467-71. PubMed ID: 14692430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Budesonide].
    Mokr K
    Dtsch Med Wochenschr; 1995 Jan; 120(4):111-2. PubMed ID: 7835236
    [No Abstract]   [Full Text] [Related]  

  • 35. Ipratropium bromide nasal spray 0.03% and beclomethasone nasal spray alone and in combination for the treatment of rhinorrhea in perennial rhinitis.
    Dockhorn R; Aaronson D; Bronsky E; Chervinsky P; Cohen R; Ehtessabian R; Finn A; Grossman J; Howland W; Kaiser H; Pearlman D; Sublett J; Ratner P; Settipane G; Sim T; Storms W; Webb R; Drda K; Wood C
    Ann Allergy Asthma Immunol; 1999 Apr; 82(4):349-59. PubMed ID: 10227333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Budesonide in grass pollen rhinitis.
    Norman PS; Creticos PS; Tobey R; Proud DG; Kagey-Sobotka A; Meyers DA; Persson T
    Ann Allergy; 1992 Oct; 69(4):309-16. PubMed ID: 1416266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of intranasal steroid budesonide on the congestion-related sleep disturbance and daytime somnolence in patients with perennial allergic rhinitis.
    Gurevich F; Glass C; Davies M; Wei W; McCann J; Fisher L; Chegini S; Mende C; Craig T
    Allergy Asthma Proc; 2005; 26(4):268-74. PubMed ID: 16270719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A clinical comparison of budesonide nasal aerosol, terfenadine and a combined therapy of budesonide and oxymetazoline in adult patients with perennial rhinitis.
    Lau SK; Wei WI; Van Hasselt CA; Sham CL; Woo J; Choa D; Engzell UC
    Asian Pac J Allergy Immunol; 1990 Dec; 8(2):109-15. PubMed ID: 1709020
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison between intranasal budesonide aerosol and budesonide dry powder in the treatment of hay fever symptoms.
    Malmberg H; Holopainen E; Simola M; Böss I; Lindqvist N
    Rhinology; 1991 Jun; 29(2):137-41. PubMed ID: 1891681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and tolerability of azelastine nasal spray in patients with allergic rhinitis compared to placebo and budesonide.
    Dorow P; Aurich R; Petzold U
    Arzneimittelforschung; 1993 Aug; 43(8):909-12. PubMed ID: 8105785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.